CYP2D6 genotyping and the use of tamoxifen in breast cancer
- PMID: 23958737
- DOI: 10.1093/jnci/djt221
CYP2D6 genotyping and the use of tamoxifen in breast cancer
Comment in
-
Response.J Natl Cancer Inst. 2014 Feb;106(2):djt380. doi: 10.1093/jnci/djt380. Epub 2014 Jan 9. J Natl Cancer Inst. 2014. PMID: 24408654 No abstract available.
-
Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer.J Natl Cancer Inst. 2014 Feb;106(2):djt379. doi: 10.1093/jnci/djt379. Epub 2014 Jan 9. J Natl Cancer Inst. 2014. PMID: 24408655 Free PMC article. No abstract available.
Comment on
-
Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.J Natl Cancer Inst. 2013 Sep 4;105(17):1332-4. doi: 10.1093/jnci/djt204. Epub 2013 Aug 19. J Natl Cancer Inst. 2013. PMID: 23958736 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical